These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29927655)

  • 1. Industry Support of Patient Advocacy Organizations: The Case for an Extension of the Sunshine Act Provisions of the Affordable Care Act.
    McCoy MS
    Am J Public Health; 2018 Aug; 108(8):1026-1030. PubMed ID: 29927655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Advocacy Organizations, Industry Funding, and Conflicts of Interest.
    Rose SL; Highland J; Karafa MT; Joffe S
    JAMA Intern Med; 2017 Mar; 177(3):344-350. PubMed ID: 28114624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Industry Support of US Patient Advocacy Organizations: An International Context.
    Kang SY; Bai G; Karas L; Anderson GF
    Am J Public Health; 2019 Apr; 109(4):559-561. PubMed ID: 30789768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the Sunshine Act: Transparency Regulation and Financial Conflicts in Health Care.
    Saver RS
    Am J Law Med; 2017 Nov; 43(4):303-343. PubMed ID: 29452562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Basics of the Sunshine Act: How It Pertains to the Practicing Orthopaedic Surgeon.
    Parisi TJ; Ferre IM; Rubash HE
    J Am Acad Orthop Surg; 2015 Aug; 23(8):455-67. PubMed ID: 26209143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry Financial Relationships in Neurosurgery in 2015: Analysis of the Sunshine Act Open Payments Database.
    de Lotbiniere-Bassett MP; McDonald PJ
    World Neurosurg; 2018 Jun; 114():e920-e925. PubMed ID: 29581013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Potential Conflicts of Interest among Otolaryngologic Patient Advocacy Organizations in 2016.
    Kondamuri NS; Rathi VK; Naunheim MR; Sethi RV; Miller AL; Varvares MA
    Otolaryngol Head Neck Surg; 2019 Dec; 161(6):967-969. PubMed ID: 31479391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
    Li DG; Singer S; Mostaghimi A
    JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Do Plastic Surgery Patients Think of Financial Conflicts of Interest and the Sunshine Act?
    Lopez J; Naved BA; Pradeep T; Pineault K; Purvis T; Macmillan A; Slezak S; May JW; Dorafshar AH
    Ann Plast Surg; 2019 Jun; 82(6):597-603. PubMed ID: 30870172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Content Analysis of Patient Advocacy Organization Policies Addressing Institutional Conflicts of Interest.
    Brems JH; McCoy MS
    AJOB Empir Bioeth; 2019; 10(4):215-221. PubMed ID: 31593523
    [No Abstract]   [Full Text] [Related]  

  • 11. The sunshine act and medical publications: Guidance from professional medical associations.
    Toroser D; DeTora L; Cairns A; Juneja R; Georgieva A; Weigel A; Pepitone K
    Postgrad Med; 2015; 127(7):752-7. PubMed ID: 26311116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Payments to Pediatricians in the Sunshine Act.
    Karas DJ; Bandari J; Browning DN; Jacobs BL; Davies BJ
    Clin Pediatr (Phila); 2017 Jul; 56(8):723-728. PubMed ID: 27663966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest.
    Ehrlich O; Wingate L; Heller C; de Melo-Martin I
    BMC Med Ethics; 2019 Dec; 20(1):96. PubMed ID: 31847854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
    Checketts JX; Sims MT; Vassar M
    JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data.
    Samuel AM; Webb ML; Lukasiewicz AM; Bohl DD; Basques BA; Russo GS; Rathi VK; Grauer JN
    Clin Orthop Relat Res; 2015 Oct; 473(10):3297-306. PubMed ID: 26088767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness.
    Rose SL
    J Law Med Ethics; 2013; 41(3):680-7. PubMed ID: 24088159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shadows amid sunshine: regulating financial conflicts in medical research.
    Saver RS
    Chest; 2014 Feb; 145(2):379-385. PubMed ID: 24493509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK.
    Rickard E; Ozieranski P; Mulinari S
    Health Policy; 2019 Dec; 123(12):1244-1250. PubMed ID: 31455562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shining light on the Sunshine Act.
    Silva E
    J Am Coll Radiol; 2013 Sep; 10(9):652-3. PubMed ID: 24007605
    [No Abstract]   [Full Text] [Related]  

  • 20. Extending the Sunshine Act From Physicians to Patient Advocacy Organizations.
    Kanter GP
    Am J Public Health; 2018 Aug; 108(8):978-979. PubMed ID: 29995484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.